Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. QS
6. BFH
7. BRO
8. SAP
9. RCUS
10. LMT

Go back to Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Vaccine experts say Moderna (MRNA) didn’t produce data critical to assessing Covid-19 vaccine - STAT

May 19, 2020 2:56 PM EDT

Vaccine experts say Moderna (NASDAQ: MRNA) didnt produce data critical to assessing Covid-19 vaccine - STAT

... More

Moderna (MRNA) Announces Proposed $1.25 Billion Public Offering of Shares of Common Stock

May 18, 2020 4:18 PM EDT

Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it has commenced an underwritten public offering of $1.25 billion in shares of common stock. In addition, Moderna expects to grant the underwriters a 30-day option to purchase up... More